Share
Market Research Report

CELL AND GENE THERAPY FOR ONCOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Therapy TypeCell Therapy (Stem Cell Therapy, T-Cell Therapy, Mesenchymal Stem Cell (MSC) Therapy, and Others) and Gene Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Therapy Gene Transfer)
  • By TechnologyCell Therapy Technology (Autologous, Allogeneic, and Xenogeneic) and Gene Therapy Technology (Viral Vector-Based Gene Therapy and Non-Viral Vector-Based Gene Therapy)
  • By IndicationBreast Cancer · Lung Cancer · Prostate Cancer · Leukaemia and Lymphoma · and Others
  • By End UserHospitals and Cancer Treatment Centers · Research and Academic Institutes · Biotechnology and Pharmaceutical Companies · and Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East and Africa
  • Published In08 May 2026
  • Report CodeCMI9477
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Market Segmentation

  • Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)

    • Cell Therapy
      • Stem Cell Therapy
      • T-Cell Therapy
      • Mesenchymal Stem Cell (MSC) Therapy
      • Others
    • Gene Therapy
      • Gene Induced Immunotherapy
      • Oncolytic Virotherapy
      • Therapy Gene Transfer

  • Technology Insights (Revenue, USD Mn, 2021 - 2033)

    • Cell Therapy Technology
      • Autologous
      • Allogeneic
      • Xenogeneic
    • Gene Therapy Technology
      • Viral Vector-Based Gene Therapy
      • Non-Viral Vector-Based Gene Therapy

  • Indication Insights (Revenue, USD Mn, 2021 - 2033)

    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Leukaemia and Lymphoma
    • Others

  • End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospitals and Cancer Treatment Centers
    • Research and Academic Institutes
    • Biotechnology and Pharmaceutical Companies
    • Others

  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa